Professor Shulamit Levenberg is the dean of the Faculty of Biomedical Engineering at the Technion – Israel Institute of Technology. She also serves as the director of the Technion Center for 3D Bioprinting and The Rina and Avner Schneur Center for Diabetes Research. Prof. Levenberg earned her PhD at the Weizmann Institute of Science, and pursued her post-doctoral research in tissue engineering at Prof. Robert Langer's lab in MIT. In 2004, she joined the Technion, where she conducts interdisciplinary research on stem cells and tissue engineering.
Her groundbreaking discoveries involve in vitro vascularization of engineered tissues where, upon implantation, the engineered vessels anastomose with the host vasculature, improving survival and perfusion of engineered grafts. Prof. Levenberg was the first to engineer vascularized tissue flaps, offering novel reconstruction techniques using engineered tissue constructs. Her pioneering work demonstrated the effect of scaffold stiffness and tensile forces on early differentiation and organization of stem cells in 3D constructs, and on alignment of vessel networks in engineered tissues. She recently developed unique stem-cell engineered tissue constructs that induce the regeneration and repair of injured spinal cords.
Prof. Levenberg was named by Scientific American as a “Research Leader” in tissue engineering, for her seminal work on vascularization of engineered tissues. She is the recipient of numerous awards and accolades, including the Krill Prize for excellence in scientific research, awarded by the Wolf Foundation, the France-Israel Foundation Prize, the Italian Excellence for Israel Prize, the Teva Research Prize, the Juludan Research Prize, and the Rappaport Prize for Biomedical Sciences.